Dyne Therapeutics
Price & Volume
Stats
See more52W Range | $8.06-$25 |
Market Cap | $3.4B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.15 |
News
See moreYahoo Finance • 24 hours ago
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance • 9 days ago
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 22 days ago
Dyne Therapeutics (DYN) Reaches Key Regulatory Milestone
Yahoo Finance • 28 days ago
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
About
CEO | Mr. John G. Cox M.B.A. |
CFO | Mr. Erick J. Lucera C.F.A., CPA |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 263 |